SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 100.78 |
| Enterprise Value ($M) | 136.45 |
| Book Value ($M) | 23.92 |
| Book Value / Share | 0.14 |
| Price / Book | 4.21 |
| NCAV ($M) | -81.89 |
| NCAV / Share | -0.48 |
| Price / NCAV | -1.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.12 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.31 |
| Current Ratio | 1.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 72.93 |
| Assets | 178.74 |
| Liabilities | 154.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Nestle Sa | 14.29 | ||
| 13G/A | BlackRock, Inc. | 4.50 | -7.00 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 15.00 | 3.74 | |
| 13G/A | Federated Hermes, Inc. | 4.04 | -55.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,405,543 | 3,409,781 | 41.22 | |
| 705,481 | 1,856,846 | 37.99 | |
| 1,882,832 | 5,115,684 | 36.81 | |
| 1,287,894 | 3,404,133 | 37.83 | |
| 717,630 | 2,375,483 | 30.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LVTX – LAVA Therapeutics N.V. | LXRX – Lexicon Pharmaceuticals, Inc. |
| LYEL – Lyell Immunopharma, Inc. | MDGL – Madrigal Pharmaceuticals, Inc. |
| MGNX – MacroGenics, Inc. |
Financial data and stock pages provided by
Fintel.io